These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 9462205
21. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors. Dattilo M, Figura N. J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516 [Abstract] [Full Text] [Related]
22. Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease. Suzuki H, Mori M, Sakaguchi AA, Suzuki M, Miura S, Ishii H. J Gastroenterol Hepatol; 1998 May; 13(5):516-20. PubMed ID: 9641651 [Abstract] [Full Text] [Related]
23. Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole. Hatlebakk JG, Berstad A. Aliment Pharmacol Ther; 1997 Dec; 11(6):1093-9. PubMed ID: 9663835 [Abstract] [Full Text] [Related]
24. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole]. Müller P, Fuchs W, Peifer-Weiss A, Simon B. Fortschr Med; 1998 Oct 10; 116(28):31-2. PubMed ID: 9844264 [No Abstract] [Full Text] [Related]
25. Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection. Hazell SL, Mitchell HM, Hanna G, Daskalopoulos G. Eur J Clin Microbiol Infect Dis; 1997 Jul 10; 16(7):530-2. PubMed ID: 9272389 [Abstract] [Full Text] [Related]
26. [Is chronic laryngitis associated with Helicobacter pylori? Results of a prospective study]. Jaspersen D, Weber R, Diehl KL, Kind M, Arps H, Draf W. Z Gastroenterol; 1998 May 10; 36(5):369-72. PubMed ID: 9654703 [Abstract] [Full Text] [Related]
27. Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis. Hsu PI, Lai KH, Chien EJ, Lin CK, Lo GH, Jou HS, Cheng JS, Chan HH, Hsu JH, Ger LP, Hsu PN, Tseng HH. Anticancer Res; 2000 May 10; 20(2B):1221-8. PubMed ID: 10810425 [Abstract] [Full Text] [Related]
28. Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors. Hirschowitz BI, Simmons J, Mohnen J. Aliment Pharmacol Ther; 2002 Feb 10; 16(2):303-13. PubMed ID: 11860414 [Abstract] [Full Text] [Related]
29. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D. Gut; 1997 Dec 10; 41(6):735-9. PubMed ID: 9462204 [Abstract] [Full Text] [Related]
30. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study. Pilotto A, Perri F, Leandro G, Franceschi M, Aging and Acid-Related Disease Study Group. Gerontology; 2006 Dec 10; 52(2):99-106. PubMed ID: 16508317 [Abstract] [Full Text] [Related]
31. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth. Nakajima N, Kuwayama H, Iwasaki A, Arakawa Y. J Clin Gastroenterol; 1995 Dec 10; 20 Suppl 2():S90-2. PubMed ID: 7594352 [Abstract] [Full Text] [Related]
32. Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients. Marusic M, Babic Z, Nesanovic M, Lucijanic-Mlinac M, Stajcar V. World J Gastroenterol; 2005 Apr 21; 11(15):2334-6. PubMed ID: 15818748 [Abstract] [Full Text] [Related]
33. Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils. Chang CC, Chen SH, Lien GS, Lee YJ, Lou HY, Hsieh CR, Fang CL, Pan S. World J Gastroenterol; 2005 Feb 21; 11(7):982-5. PubMed ID: 15742400 [Abstract] [Full Text] [Related]
34. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. Kyzekova J, Mour J. Hepatogastroenterology; 1999 Feb 21; 46(27):2048-56. PubMed ID: 10430396 [Abstract] [Full Text] [Related]
35. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. Giannini E, Romagnoli P, Fasoli A, Chiarbonello B, Malfatti F, Botta F, Risso D, Lantieri PB, Savarino V, Testa R. Am J Gastroenterol; 2000 Oct 21; 95(10):2762-7. PubMed ID: 11051345 [Abstract] [Full Text] [Related]
36. Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis. Gough AL, Long RG, Cooper BT, Fosters CS, Garrett AD, Langworthy CH. Aliment Pharmacol Ther; 1996 Aug 21; 10(4):529-39. PubMed ID: 8853756 [Abstract] [Full Text] [Related]
37. [The role of apoptosis and proliferation of epitheliocytes in morphogenesis of Helicobacter pylori-associated gastritis]. Kogan EA, Bondarenko OIu, Sklianskaia OA, Lapina TL, Demura SA, Azov AG, Ivashkin VT. Arkh Patol; 2003 Aug 21; 65(6):22-6. PubMed ID: 14964963 [Abstract] [Full Text] [Related]
38. Lansoprazole: an update of its place in the management of acid-related disorders. Matheson AJ, Jarvis B. Drugs; 2001 Aug 21; 61(12):1801-33. PubMed ID: 11693467 [Abstract] [Full Text] [Related]
39. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Holtmann G, Cain C, Malfertheiner P. Gastroenterology; 1999 Jul 21; 117(1):11-6. PubMed ID: 10381904 [Abstract] [Full Text] [Related]
40. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. Feldman M, Cryer B, Sammer D, Lee E, Spechler SJ. Am J Physiol; 1999 Dec 21; 277(6):G1159-64. PubMed ID: 10600812 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]